CORe presented the below oral presentations at ECTRIMS 2024
Sharmin et al
Müller et al
Guiding Treatment De-escalation in Relapsing Remitting Multiple Sclerosis
CORe presented the below posters at ECTRIMS 2024
Dzau et al
Giofre et al
Kalincik et al
Lizak et al
Managing disease activity during treatment with natalizumab in relapse-remitting multiple sclerosis
Muller et al
A standardised definition of progression independent of relapse activity in multiple sclerosis
Roos et al
Preserving neurological function in patients at high and low risk of aggressive multiple sclerosis
Roberts et al
Sharmin et al
How patients with neuromyelitis optica spectrum disorder accumulate disability
Susin et al
Polyhedral predictive model for multiple sclerosis: an external validation
CORe presented the below posters at ECTRIMS 2023
Poster 1 – Roos et al
Poster 2 – Moradi et al
The prognostic role of Vitamin D in predicting treatment response in MS
Poster 3 – Moradi et al
The prognostic role of volumetric MRI for predicting treatment response in MS
We presented the below posters at the ECTRIMS Conference 2022.
Poster 1 – Kalincik et al
Poster 2 – Sharmin et al
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Poster 3 – Moradi et al
We presented the below posters at the MS Australia
Progress in MS Research Scientific Conference 2022.
Poster 1 – Roos et al
Poster 2 – Roos et al
Effects of high- and low- efficacy therapy in secondary progressive multiple sclerosis
Poster 3 – Roberts et al
Lessons learned in the first two years of a specialist multiple sclerosis cognitive clinic
Poster 4 – Diouf et al
Poster 5 – Diouf et al
Variability of the response to immunotherapy among sub-groups of patients with multiple sclerosis
Poster 6 – Moradi et al
MS Cohorts and Treatment Utilization in the Middle East
Poster 7 – Sharmin et al
Confirmed disability progression as a marker of permanent disability in multiple sclerosis
We presented the below posters at ECTRIMS Congress 2021.
Poster 1 – Moradi et al
External Validation of Crystal Ball 1.2 on MSBase Middle Eastern Cohort